One of the major stories in multiple myeloma in 2024 was the comeback of belantamab mafodotin (Blenrep) after it had been ...

Let’s look specifically at dexamethasone, a common corticosteroid in emergency medicine, and use current research to describe what the drug does and look at select situations in prehospital care ...

The FDA granted approval to nilotinib (Danziten) on November 14, 2024, for the treatment of adult patients with newly ...

The DGHS inquiry revealed no evidence against Delhi government hospitals regarding spurious drugs, following LG V K Saxena's ...

Generic drug repurposing is an underused but promising tool for finding new, affordable therapies. Creating a pull incentive ...

The report states that drug samples were not found to be “substandard” or “spurious”, as alleged in a complaint to the Delhi ...

Specifically, the restrictions meant that patients who had received prior treatment with a combination of isatuximab, pomalidomide, and dexamethasone ... of the drug to patients who would be ...

The need for oral steroids can be explained to the parents, with the choice of oral dexamethasone being based on its efficacy and palatability. Additionally, the standard weight-based dosage of 0.15 ...

The introduction of new agents immunomodulatory drugs (IMiDs) and proteasome inhibitors ... FDA approval in 2006 for MM in combination with dexamethasone in patients who progressed after one ...

London: GSK plc has announced the US Food and Drug Administration (FDA) has accepted for review a Biologics License ...

If it’s challenging to lose weight despite making changes to your diet and increasing your physical activity, you may be wondering whether a prescription weight loss medication is right for you.